大面创伤患者临床重要差异最小:一个前性队列研究
Aparna Ganesan1, Neeti Rustagi2, Amanjot Kaur3
1Ex-Junior Resident, Oral & Maxillofacial Surgery, Department of Dentistry, All India Institute of Medical Sciences, Jodhpur, India.
The British journal of oral & maxillofacial surgery
|February 9, 2024
概括
这项研究确定了口面创伤患者疼痛和咬伤力的最小临床重要差异 (MCID). 临床相关的改善包括减少2.4-2.5点的疼痛,增加147.9-159.1N的咬伤力.
科学领域:
- 口腔和牙面部外科手术
- 疼痛管理 疼痛管理
- 康复医学 康复医学 康复医学
背景情况:
- 面创伤 (MFT) 显著影响患者的生活质量.
- 评估MFT后的功能恢复需要可靠的结果措施.
- 确定临床上重要的最小差异 (MCID) 对于解释治疗结果至关重要.
研究的目的:
- 用视觉模拟尺度-数值评分尺度 (VAS-NRS) 来估计疼痛的MCID.
- 估计MFT患者中平均咬伤力 (MBF) 的MCID.
- 为在MFT治疗后的功能康复提供临床相关的基准.
主要方法:
- 一项对120名MFT患者的队列研究,这些患者接受了AO原则的治疗.
- 测量手术前和4周后的VAS-NRS疼痛和MBF.
- 使用变化差异 (CD) 和接收器操作特征 (ROC) 曲线方法来确定MCID.
- 通过四项题评估患者的观点.
主要成果:
- 疼痛的MCID:2.4 (CD方法) 和2.5 (ROC方法).
- MBF 的 MCID: 147.9 N (CD 方法) 和 159.1 N (ROC 方法).
- ROC分析显示,在疼痛和MBF中,对MCID的敏感性很高.
结论:
- 在VAS-NRS上减少2.4-2.5分的疼痛对于MFT患者来说具有临床意义.
- 在MBF中获得147.9-159.1N的收益意味着有意义的功能恢复.
- 这些MCID值作为评估MFT康复治疗有效性的有价值指标.
相关概念视频
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...